Moreno Evelyn V trimmed its position in Danaher Co. (NYSE:DHR) by 2.6% in the 2nd quarter, HoldingsChannel reports. The firm owned 65,602 shares of the conglomerate’s stock after selling 1,764 shares during the quarter. Danaher makes up about 2.9% of Moreno Evelyn V’s portfolio, making the stock its 6th largest position. Moreno Evelyn V’s holdings in Danaher were worth $9,376,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in DHR. Sigma Planning Corp raised its position in Danaher by 19.4% during the second quarter. Sigma Planning Corp now owns 8,224 shares of the conglomerate’s stock valued at $1,175,000 after acquiring an additional 1,338 shares in the last quarter. Kavar Capital Partners LLC raised its position in Danaher by 1.9% during the second quarter. Kavar Capital Partners LLC now owns 42,820 shares of the conglomerate’s stock valued at $6,120,000 after acquiring an additional 790 shares in the last quarter. Watch Point Trust Co raised its position in Danaher by 18.8% during the second quarter. Watch Point Trust Co now owns 28,882 shares of the conglomerate’s stock valued at $4,128,000 after acquiring an additional 4,574 shares in the last quarter. Stephens Inc. AR raised its position in Danaher by 1.1% during the second quarter. Stephens Inc. AR now owns 46,423 shares of the conglomerate’s stock valued at $6,635,000 after acquiring an additional 483 shares in the last quarter. Finally, TRUE Private Wealth Advisors purchased a new position in Danaher during the second quarter valued at approximately $95,000. Hedge funds and other institutional investors own 79.35% of the company’s stock.
DHR traded up $0.86 during trading on Thursday, hitting $137.22. The company’s stock had a trading volume of 52,593 shares, compared to its average volume of 2,374,486. The company has a quick ratio of 1.91, a current ratio of 2.32 and a debt-to-equity ratio of 0.33. Danaher Co. has a twelve month low of $94.59 and a twelve month high of $145.50. The business’s fifty day moving average price is $141.46. The company has a market cap of $99.31 billion, a price-to-earnings ratio of 30.46, a price-to-earnings-growth ratio of 2.50 and a beta of 0.94.
Several research analysts recently weighed in on DHR shares. Royal Bank of Canada set a $134.00 price target on Danaher and gave the company a “hold” rating in a research report on Friday, July 19th. Robert W. Baird lifted their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Needham & Company LLC reiterated a “buy” rating and set a $155.00 price target (up from $142.00) on shares of Danaher in a research report on Friday, July 19th. Wolfe Research initiated coverage on Danaher in a report on Thursday, May 30th. They issued an “outperform” rating on the stock. Finally, Piper Jaffray Companies raised their price objective on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Three equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $143.54.
In other news, SVP William King sold 12,950 shares of Danaher stock in a transaction that occurred on Wednesday, May 29th. The stock was sold at an average price of $129.92, for a total value of $1,682,464.00. Following the sale, the senior vice president now directly owns 29,070 shares of the company’s stock, valued at $3,776,774.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction that occurred on Friday, July 26th. The stock was sold at an average price of $144.04, for a total value of $145,480.40. Following the completion of the sale, the insider now directly owns 20,889 shares in the company, valued at $3,008,851.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 361,850 shares of company stock worth $49,587,520. 11.40% of the stock is owned by corporate insiders.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: Why is the ROA ratio important?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.